AMs recommend that pharmacists have access to palliative care data in Wales

AMs recommend that pharmacists have access to palliative care data in Wales

July 18 2018 Community pharmacists should be among those health professionals who are alerted to...

APTUK questions claims about pharmacy technicians’ desire to supervise medicines supplies

APTUK questions claims about pharmacy technicians’ desire to supervise medicines supplies

July 18 2018 The Association of Pharmacy Technicians UK is questioning a survey on pharmacy...

Community pharmacy briefing for MPs due this week

Community pharmacy briefing for MPs due this week

July 16 2018 Community pharmacy organisations are due to brief MPs at Westminster on Tuesday 17...

GPhC asks for views on publication and disclosure policy update in light of GDPR

GPhC asks for views on publication and disclosure policy update in light of GDPR

July 10 2018 The General Pharmaceutical Council is seeking views on how its publication and...

CMO concludes cannabis products should move out of Schedule 1 classification

CMO concludes cannabis products should move out of Schedule 1 classification

July 9 2018 The Chief Medical Officer has recommended rescheduling cannabis-based products as...

  • AMs recommend that pharmacists have access to palliative care data in Wales

    AMs recommend that pharmacists have access to palliative care data in Wales

    Wednesday, 18 July 2018 17:41
  • APTUK questions claims about pharmacy technicians’ desire to supervise medicines supplies

    APTUK questions claims about pharmacy technicians’ desire to supervise medicines supplies

    Wednesday, 18 July 2018 17:17
  • Community pharmacy briefing for MPs due this week

    Community pharmacy briefing for MPs due this week

    Monday, 16 July 2018 15:31
  • GPhC asks for views on publication and disclosure policy update in light of GDPR

    GPhC asks for views on publication and disclosure policy update in light of GDPR

    Tuesday, 10 July 2018 09:29
  • CMO concludes cannabis products should move out of Schedule 1 classification

    CMO concludes cannabis products should move out of Schedule 1 classification

    Monday, 09 July 2018 09:18

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

JoggingJune 15 2016

NICE has announced it is to draw up a new guideline on how community pharmacies can promote health and wellbeing. It has issued a short consultation on the draft scope of what the guideline should cover, although the guideline itself is not anticipated until June 2018.

This initial stage of the work is to seek views on who the guideline should be for, its focus, settings that will be covered, activities and services to be included, and economic considerations. It will also propose what the main outcomes should be and sets out the context for existing community pharmacy involvement in health promotion. The guideline will also be used to develop a NICE quality standard.

It is proposed that the intended target audience for the guideline will be local authorities, community pharmacies and commissioners of health-promotion activities that can be conducted in pharmacies. However, NICE envisages that other people who may find the guideline relevant are pharmacy customers and patients, private and voluntary sector organisations involved in health promotion and GPs.

It will take into account the nature of community pharmacy services taking place in commercial settings such as supermarkets, as well as healthcare and community settings. However, it is not intended to include online pharmacy services or to reflect hospital pharmacies or those that people use as a result of referral or signposting from a community pharmacy.

Proposed key areas to be covered include promotional materials such as posters, TV or computer screens, self-help booklets and leaflets. It will also include the offering of advice, education or behavioural support, such as ‘Making Every Contact Count’, which encourages conversations to make people better aware of healthier lifestyles.

“Community pharmacies are well positioned to promote health and wellbeing to all members of the local community, including people who do not visit GPs or other healthcare services. As a result, they can help reduce both health inequalities and individual health risks,” says the draft. “Many health conditions can be prevented by people adopting healthier behaviours. These include type 2 diabetes, cardiovascular disease and conditions related to obesity and smoking.”

Specific areas considered for interventions will include:

• alcohol use (such as brief advice)
• cancer awareness (such as information on the risks and benefits of sunlight exposure)
• healthy eating, weight management and physical activity
• lower back pain (such as information on how exercise can help)
• mental health and wellbeing (such as advice on how to get a good night's sleep)
• osteoporosis (such as advice on how exercise and diet can help)
• sexual health (such as advice on contraception)
• smoking (such as providing smoking cessation support).

It will not cover community pharmacy services not related to promoting health and wellbeing such as treating disease, dispensing, other medicine or device services, vaccinations, self-care for disease management, and urgent care.
To get involved in the consultation NICE has asked for comments to be fed through registered stakeholder organisations. Organisations that are not already registered with NICE need to do so by July 7.

Links:

NICE guideline in development

NICE guideline scope

Legal & Policy News

July 20 2018 Community pharmacy representatives have briefed MPs about the role pharmacy teams can play in helping manage long term conditions.
July 20 2018 A consultation asking for views on how the safety features required under the Falsified Medicines Directive should be implemented has been issued. The MHRA has launched the consultation with...